Potential new drug to treat severe, uncontrolled asthma

Trial results suggest treatment could be used as an add-on therapy for severely asthmatic patientsTwo phase III, double-blind, randomised controlled trials including more than 2500 participants looked at the safety and efficacy of benralizumab injections as an add-on therapy for patients with severe, uncontrolled asthma.Benralizumab targets the IL-5 receptor that drives the proliferation of eosinophils –